Jonathan W Riess

Jonathan W Riess

UNVERIFIED PROFILE

Are you Jonathan W Riess?   Register this Author

Register author
Jonathan W Riess

Jonathan W Riess

Publications by authors named "Jonathan W Riess"

Are you Jonathan W Riess?   Register this Author

49Publications

1042Reads

9Profile Views

MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel R1004G Mutation.

Oncologist 2019 Aug 7. Epub 2019 Aug 7.

Department of Internal Medicine, Division of Hematology/Oncology, UC Davis School of Medicine, UC Davis Comprehensive Cancer Center, Sacramento, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0230DOI Listing
August 2019

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma.

Clin Lung Cancer 2019 Jul 19;20(4):e489-e491. Epub 2019 Apr 19.

Division of Hematology/Oncology, Department of Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.04.007DOI Listing
July 2019

A Population-Based Study of Incidence and Survival of 1588 Thymic Malignancies: Results From the California Cancer Registry.

Clin Lung Cancer 2019 Jun 14. Epub 2019 Jun 14.

Division of Hematology and Oncology, Department of Internal Medicine, UC Davis School of Medicine, UC Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.06.005DOI Listing
June 2019

EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade.

Clin Lung Cancer 2019 May 27;20(3):e238-e241. Epub 2018 Dec 27.

Department of Internal Medicine, Division of Hematology/Oncology, UC Davis School of Medicine and UC Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183035
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.12.015DOI Listing
May 2019

Increased Galectin-1 Expression in Thymic Epithelial Tumors.

Clin Lung Cancer 2019 May 21;20(3):e356-e361. Epub 2018 Dec 21.

Department of Radiation Oncology, Stanford University School of Medicine Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.12.005DOI Listing
May 2019

In Search of an Oncogene Driver for Squamous Lung Cancer.

JAMA Oncol 2018 09;4(9):1197-1198

University of California Davis Comprehensive Cancer Center, Sacramento.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0774DOI Listing
September 2018

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders.

J Clin Oncol 2018 07 10;36(19):1905-1912. Epub 2018 May 10.

Giulia C. Leonardi, Sasha Kravets, Suzanne E. Dahlberg, and Mark M. Awad, Dana-Farber Cancer Institute; Justin F. Gainor and Roxana Azimi, Massachusetts General Hospital; Lydia Gedmintas, Brigham and Women's Hospital, Boston, MA; Mehmet Altan, MD Anderson Cancer Center, Houston, TX; Hira Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center; Matthew D. Hellmann, Weill Cornell Medical College, and Parker Institute for Cancer Immunotherapy, New York, NY; and Jonathan W. Riess, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553840PMC
July 2018

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

J Clin Oncol 2018 05 27;36(14):1412-1418. Epub 2018 Mar 27.

Brigette B.Y. Ma, Edwin P. Hui, Kwok-Wai Lo, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, and Anthony T.C. Chan, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China; Wan-Teck Lim, National Cancer Centre; Boon-Cher Goh, National University Cancer Institute of Singapore; Alex Y.C. Chang, Johns Hopkins University School of Medicine; Akhil Chopra, OncoCare Cancer Centre, Singapore; Adam Pettinger, Nathan R. Foster, Charles Erlichman, Jun Yin, and Brian A. Costello, Mayo Clinic, Rochester, MN; Jonathan W. Riess, University of California Davis Comprehensive Cancer Center, Sacramento; Barbara J. Gitlitz, University of Southern California Keck School of Medicine, Los Angeles; Dean W. Lim, City of Hope Comprehensive Cancer Center, Duarte, CA; Mark Agulnik, Northwestern University, Evanston, IL; Julie A. Kish and Christine H. Chung, Moffitt Cancer Center, University of South Florida, Tampa, FL; Douglas R. Adkins, Washington University School of Medicine, St Louis, MO; Kevin J. Cullen, University of Maryland, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941615PMC
May 2018

Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.

Int J Radiat Oncol Biol Phys 2018 03 6;100(3):647-651. Epub 2017 Nov 6.

Department of Radiation Oncology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.10.045DOI Listing
March 2018

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.

Lung Cancer 2017 10 31;112:165-168. Epub 2017 Aug 31.

University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.015DOI Listing
October 2017

Multidisciplinary Care.

Cancer Treat Res 2016;170:285-300

Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis Comprehensive Cancer Center, 4501 X Street, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-319-40389-2_13
Publisher Site
http://dx.doi.org/10.1007/978-3-319-40389-2_13DOI Listing
June 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.

Clin Lung Cancer 2017 01 24;18(1):1-4. Epub 2016 Dec 24.

University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304163038
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2016.12.011DOI Listing
January 2017

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3717-3718

Jonathan W. Riess, Primo N. Lara Jr, and David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477925PMC
November 2016

Pruritus as a Paraneoplastic Symptom of Thymoma.

J Thorac Oncol 2015 Nov;10(11):e110-2

*Division of Oncology, Department of Medicine, †Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California; ‡Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California; §Stanford Thoracic Oncology, Stanford Health Care, Stanford, California; ¶Department of Dermatology, Stanford University School of Medicine, Stanford, California; ‖Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China; #Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; **Department of Pathology, ††Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California; ‡‡Division of Oncology, Department of Medicine, Ukiah Valley Rural Health Center, Ukiah, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720251PMC
November 2015

Dovitinib and erlotinib in patients with metastatic non-small cell lung cancer: A drug-drug interaction.

Lung Cancer 2015 Sep 22;89(3):280-6. Epub 2015 Jun 22.

Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613811PMC
September 2015

Diffuse high intensity PD-L1 staining in thymic epithelial tumors.

J Thorac Oncol 2015 Mar;10(3):500-8

*Division of Oncology, Department of Internal Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; †Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA; ‡Department of Pathology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA; and §Department of Health and Research Policy, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720257PMC
March 2015

GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.

Anticancer Res 2015 Feb;35(2):669-76

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, U.S.A.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973531PMC
February 2015

Pemetrexed in patients with thymic malignancies previously treated with chemotherapy.

Lung Cancer 2015 Jan 15;87(1):34-8. Epub 2014 Nov 15.

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.11.006DOI Listing
January 2015

Left behind? Drug discovery in extensive-stage small-cell lung cancer.

Clin Lung Cancer 2014 Mar 3;15(2):93-5. Epub 2014 Jan 3.

University of California Davis School of Medicine and UC Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2013.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184801PMC
March 2014

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.

Cancer Discov 2013 Dec 26;3(12):1364-77. Epub 2013 Sep 26.

Departments of 1Pediatrics, 2Genetics, and 5Medicine-Oncology, 3Vincent Coates Mass Spectrometry Laboratory, Stanford University, Stanford; and 4Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Cancer Center, University of California Davis School of Medicine, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864571PMC
December 2013

A patient with anaplastic lymphoma kinase-positive non-small cell lung cancer with development of leptomeningeal carcinomatosis while on targeted treatment with crizotinib.

J Natl Compr Canc Netw 2013 Apr;11(4):389-94

Department of Medicine, Division of Oncology, Division of Neuro-Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329611PMC
http://dx.doi.org/10.6004/jnccn.2013.0054DOI Listing
April 2013

A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab.

J Thorac Oncol 2013 Feb;8(2):e17-8

Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31827690daDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552378PMC
February 2013

Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.

J Thorac Oncol 2012 Dec;7(16 Suppl 5):S385-6

Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826df166DOI Listing
December 2012

Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.

Clin Adv Hematol Oncol 2012 Apr;10(4):226-34

Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
April 2012

Targeting FGFR, ephrins, Mer, MET, and PDGFR-α in non-small cell lung cancer.

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1797-8

Stanford University/Stanford Cancer Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000407562.07029.52DOI Listing
November 2011